Digital Therapeutics Market

Digital Therapeutics Market

Digital Therapeutics Market Forecasts to 2030 - Global Analysis By Type (Disease Management and Treatment DTx, Disease Prevention DTx), Service Type (Solutions/Software, Device, Service and Hardware), Purchase Mode (Individual and Group Purchase Organization), Sales Channel (Business-to-Consumer (B2C) and Business-to-Business (B2B)), End User and By Geography

4.4 (58 reviews)
4.4 (58 reviews)
Published: 2023 ID: SMRC23391

This report covers the impact of COVID-19 on this global market

According to Stratistics MRC, the Global Digital Therapeutics Market is accounted for $6.68 billion in 2023 and is expected to reach $25.24 billion by 2030 growing at a CAGR of 20.9% during the forecast period. In order to treat, manage, and prevent a wide range of diseases and disorders, digital therapeutics (DTx) delivers medical interventions directly to patients using evidence-based, clinically evaluated software and devices. Digital therapeutics, for instance, can assist patients in managing their symptoms on their own, enhancing their quality of life and other clinical endpoints. By offering therapeutics through smartphones, mobile devices, and comparable modalities, these digital modalities help to reduce the gaps in healthcare.

According to the International Diabetes Federation, globally, the number of people with diabetes aged 20–79 reached 537 million in 2021 from 425 million in 2017. This number is further estimated to reach 643 million by 2030.

Market Dynamics:


Growing incidence of preventable chronic diseases

The high prevalence and incidence rate of chronic diseases is a major concern for healthcare systems across the globe. The treatment of patients with chronic diseases is a significant challenge, as psychosomatic or bio psychic factors very often influence these patients. As chronic diseases are often associated with high levels of uncertainty, patients need to change their behavior as part of a new self-care lifestyle. Furthermore, many chronic disorders and conditions are progressive, and their incidence increases with age. As a result, with significant growth in the global geriatric population, chronic disorders are expected to rise further in the coming years.


Patient data privacy concerns

In many countries, various health apps are deprived of appropriate approvals, leading to concerns of product & data quality, reliability in treatment decisions, patient privacy, security, and the responsible use of data. Digital therapeutics providers have access to patient information and are forbidden from sharing the information with anyone not involved in treating that patient. However, with the integration of data using digital tools, the patient’s data is at risk of being accessed by any healthcare professional not related to the patient’s treatment program.


Strategic initiatives by manufacturers

Strategic initiatives practice supports companies undertaking the most important growth or expansion projects. While organizations are normally well-geared to manage the day-to-day aspects of business efficiently, major new strategic initiatives tend to be complex projects with multiple workstreams involved. The team helps clients maintain focus on business-as-usual functions by dexterously supporting the unique and complex task flows that accompany Greenfield integration or post-merger integration.


Reluctance among patients to adopt digital therapeutics

Motivating people to use digital therapeutics and building their confidence is a major threat faced by digital therapeutics providers. While older and underserved populations show maximum susceptibility to diseases and the highest occurrence rates, they are the least likely to use digital therapeutics products due to low technology literacy levels. Furthermore, the limit of how much behavioural change will be observed with digital therapeutics is still undefined.

Covid-19 Impact

The COVID-19 pandemic is anticipated to have a positive effect on the global market for digital therapeutics due to increased awareness of the value of digital health, an increase in the prevalence of mental illness, and a rise in the rate of drug abuse. Additionally, because people were forced to stay at home due to the pandemic, there was a decrease in physical activity, an increase in unhealthy lifestyle choices, and a rise in stress levels, all of which contributed to the prevalence of chronic diseases. As a result, DTx hardware and software are in greater demand all over the world. Additionally, the market is growing as a result of recent regulatory approvals for treatments based on DTX being more relaxed.

The disease management and treatment DTx segment is expected to be the largest during the forecast period

Over the forecast period, it is anticipated that the disease management and treatment DTx segment will hold the largest market share. This is attributed to the rise in chronic disease prevalence, the availability of affordable digital therapeutic solutions for disease management, rising investments in digital therapeutics, and the need to reduce healthcare costs due to the rising economic burden of healthcare costs.

The business-to-business (B2B) segment is expected to have the highest CAGR during the forecast period

The business-to-business (B2B) segment is growing at the highest CAGR in the market. This is attributed to increasing alertness among providers, payers, and employers about the benefits of digital therapeutics and the inclination of pharmaceutical companies to integrate digital therapeutics with their drug products.

Region with largest share:

Throughout the forecast period, North America is anticipated to rule the market. The increasing prevalence of patients with chronic illnesses and mental health conditions, such as substance use disorders, is responsible for the dominance of this regional market. Moreover, the introduction of these devices in the region is also anticipated to increase as a result of an increase in collaborations and agreements among the major players to concentrate on the research and development of these products.

Region with highest CAGR:

Due to the increased adoption of technologically advanced products and advantageous government policies, the Asia-Pacific market is estimated to witness the highest compound annual growth rate. The need for healthcare IT systems has been growing as they make it possible to manage hospitals' clinical, financial, and administrative aspects effectively. Additionally, it is anticipated that the widespread use of inexpensive mobile devices and the internet will increase demand for these products, spurring regional market expansion.

Key players in the market

Some of the key players profiled in the Digital Therapeutics Market include 2Morrow, Inc, Akili Interactive Labs, Inc., BigHealth , Canary Health Inc., DarioHealth Corp., Dthera Sciences, Fitbit LLC, GAIA AG, HYGIEIA, Limbix Health, Inc. , Livongo Health, Inc., Mango Health Inc., Medtronic Plc., Noom, Inc., Omada Health, Inc., Pear Therapeutics, Inc., Propeller Health (ResMed), Voluntis, Inc. and Welldoc, Inc.

Key Developments:

In January 2023, Lupin, a wholly-owned subsidiary of Lupin Limited, announced the launch of its therapeutics solution, LYFE. LYFE is India’s only evidence-based holistic heart care programme that significantly reduces the risk of a heart attack and improves vitals and quality of life for cardiac patients.

In October 2022, Fitbit Health Solutions introduced a partnership with Pretaa that seeks to improve outcomes for Americans and their families affected by substance abuse by introducing health and activity data in Pretaa’s substance abuse recovery app.

In August 2022, Akili Inc., the maker of a video game-like digital therapeutic for children with ADHD, announced the merger with a special-purpose acquisition company Social Capital Suvretta Holdings Corp.

Types Covered:
• Disease Management and Treatment DTx
• Disease Prevention DTx

Service Types Covered:
• Solutions/Software
• Device
• Service
• Hardware

Purchase Modes Covered:
• Individual
• Group Purchase Organization

Sales Channels Covered:
• Business-to-Consumer (B2C)
• Business-to-Business (B2B)

End Users Covered:
• Preventive
• Treatment/Care-related

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026 and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Digital Therapeutics Market, By Type
5.1 Introduction
5.2 Disease Management and Treatment DTx
5.3 Disease Prevention DTx

6 Global Digital Therapeutics Market, By Service Type
6.1 Introduction
6.2 Solutions/Software
6.3 Device
6.4 Service
6.5 Hardware

7 Global Digital Therapeutics Market, By Purchase Mode
7.1 Introduction
7.2 Individual
7.3 Group Purchase Organization

8 Global Digital Therapeutics Market, By Sales Channel
8.1 Introduction
8.2 Business-to-Consumer (B2C)
8.2.1 Patients
8.2.2 Caregivers
8.3 Business-to-Business (B2B)
8.3.1 Payers
8.3.2 Healthcare Provider
8.3.3 Employers
8.3.4 Pharmaceutical Companies
8.3.5 Other Business-to-Business (B2B)

9 Global Digital Therapeutics Market, By End User
9.1 Introduction
9.2 Preventive
9.2.1 Prediabetes
9.2.2 Obesity
9.2.3 Nutrition
9.2.4 Lifestyle Management
9.2.5 Other Preventives
9.3 Treatment/Care-related
9.3.1 Diabetes
9.3.2 CNS Disorders Mental Health Disorder Other CNS Disorders
9.3.3 Chronic Respiratory Disorders
9.3.4 Musculoskeletal Disorders
9.3.5 Cardiovascular Diseases
9.3.6 Smoking Cessation
9.3.7 Medication Adherence
9.3.8 Gastrointestinal Disorders
9.3.9 Substance Use & Addiction Management
9.3.10 Rehabilitation & Patient Care
9.3.11 Other Treatment/Care-related

10 Global Digital Therapeutics Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa

11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling
12.1 2Morrow, Inc
12.2 Akili Interactive Labs, Inc.
12.3 BigHealth
12.4 Canary Health Inc.
12.5 DarioHealth Corp.
12.6 Dthera Sciences
12.7 Fitbit LLC
12.8 GAIA AG
12.10 Limbix Health, Inc.
12.11 Livongo Health, Inc.
12.12 Mango Health Inc.
12.13 Medtronic Plc.
12.14 Noom, Inc.
12.15 Omada Health, Inc.
12.16 Pear Therapeutics, Inc.
12.17 Propeller Health (ResMed)
12.18 Voluntis, Inc.
12.19 Welldoc, Inc.

List of Tables
1 Global Digital Therapeutics Market Outlook, By Region (2021-2030) ($MN)
2 Global Digital Therapeutics Market Outlook, By Type (2021-2030) ($MN)
3 Global Digital Therapeutics Market Outlook, By Disease Management and Treatment DTx (2021-2030) ($MN)
4 Global Digital Therapeutics Market Outlook, By Disease Prevention DTx (2021-2030) ($MN)
5 Global Digital Therapeutics Market Outlook, By Service Type (2021-2030) ($MN)
6 Global Digital Therapeutics Market Outlook, By Solutions/Software (2021-2030) ($MN)
7 Global Digital Therapeutics Market Outlook, By Device (2021-2030) ($MN)
8 Global Digital Therapeutics Market Outlook, By Service (2021-2030) ($MN)
9 Global Digital Therapeutics Market Outlook, By Hardware (2021-2030) ($MN)
10 Global Digital Therapeutics Market Outlook, By Purchase Mode (2021-2030) ($MN)
10 Global Digital Therapeutics Market Outlook, By Individual (2021-2030) ($MN)
10 Global Digital Therapeutics Market Outlook, By Group Purchase Organization (2021-2030) ($MN)
13 Global Digital Therapeutics Market Outlook, By Sales Channel (2021-2030) ($MN)
14 Global Digital Therapeutics Market Outlook, By Business-to-Consumer (B2C) (2021-2030) ($MN)
15 Global Digital Therapeutics Market Outlook, By Patients (2021-2030) ($MN)
16 Global Digital Therapeutics Market Outlook, By Caregivers (2021-2030) ($MN)
17 Global Digital Therapeutics Market Outlook, By Business-to-Business (B2B) (2021-2030) ($MN)
18 Global Digital Therapeutics Market Outlook, By Payers (2021-2030) ($MN)
19 Global Digital Therapeutics Market Outlook, By Healthcare Provider (2021-2030) ($MN)
20 Global Digital Therapeutics Market Outlook, By Employers (2021-2030) ($MN)
21 Global Digital Therapeutics Market Outlook, By Pharmaceutical Companies (2021-2030) ($MN)
22 Global Digital Therapeutics Market Outlook, By Other Business-to-Business (B2B) (2021-2030) ($MN)
23 Global Digital Therapeutics Market Outlook, By End User (2021-2030) ($MN)
24 Global Digital Therapeutics Market Outlook, By Preventive (2021-2030) ($MN)
25 Global Digital Therapeutics Market Outlook, By Prediabetes (2021-2030) ($MN)
26 Global Digital Therapeutics Market Outlook, By Obesity (2021-2030) ($MN)
27 Global Digital Therapeutics Market Outlook, By Nutrition (2021-2030) ($MN)
28 Global Digital Therapeutics Market Outlook, By Lifestyle Management (2021-2030) ($MN)
29 Global Digital Therapeutics Market Outlook, By Other Preventive Applications (2021-2030) ($MN)
30 Global Digital Therapeutics Market Outlook, By Treatment/Care-related (2021-2030) ($MN)
31 Global Digital Therapeutics Market Outlook, By Diabetes (2021-2030) ($MN)
32 Global Digital Therapeutics Market Outlook, By CNS Disorders (2021-2030) ($MN)
33 Global Digital Therapeutics Market Outlook, By Chronic Respiratory Disorders (2021-2030) ($MN)
34 Global Digital Therapeutics Market Outlook, By Musculoskeletal Disorders (2021-2030) ($MN)
35 Global Digital Therapeutics Market Outlook, By Cardiovascular Diseases (2021-2030) ($MN)
36 Global Digital Therapeutics Market Outlook, By Smoking Cessation (2021-2030) ($MN)
37 Global Digital Therapeutics Market Outlook, By Medication Adherence (2021-2030) ($MN)
38 Global Digital Therapeutics Market Outlook, By Gastrointestinal Disorders (2021-2030) ($MN)
39 Global Digital Therapeutics Market Outlook, By Substance Use & Addiction Management (2021-2030) ($MN)
40 Global Digital Therapeutics Market Outlook, By Rehabilitation & Patient Care (2021-2030) ($MN)
41 Global Digital Therapeutics Market Outlook, By Other Treatment/Care-related Applications (2021-2030) ($MN)

Note: Tables for North America, Europe, Asia Pacific, South America and Middle East & Africa Regions are also represented in the same manner as above.

List of Figures


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.

Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.

For more details about research methodology, kindly write to us at

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.


Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.